Spyros Polyviou

Director, Alliance for Rare Disorders, Republic of Cyprus

Spyros Polyviou is Director of the Cyprus Alliance for Rare Disorders, where he leads national and European initiatives supporting the advancement of treatments for rare diseases through policy development, patient engagement, and system-level collaboration. He holds an MBA and a degree in Sociology and is a trained patient expert through the EURORDIS Academy in Medicines Research & Development and Scientific Innovation & Translational Research, as well as the EUPATI Patient Experts Programme. He contributes to national health committees and EU-funded projects addressing diagnostic pathways, research translation, and equitable access to innovative therapies for people living with rare diseases.

Dear delegates,

In light of the latest developments and as a precautionary measure, the Cyprus Presidency of the Council of the EU 2026 has decided to postpone this week’s Presidency Conference Advancement of Treatments for Rare Diseases, scheduled to take place in Cyprus 5–6 March 2026.

Further information regarding possible re-arrangement and new dates will be communicated in due course.

We apologise for the inconvenience caused by these adjustments and thank you for your understanding.

Yours sincerely,
The Organizing Committee
Conference “Advancement of Treatments for Rare Diseases”
Cyprus Presidency of the Council of the European Union 2026